Has the bloom gone out of lorcaserin following the CAMELLIA-TIMI61 trial?

Expert Opin Pharmacother. 2021 Feb;22(3):261-264. doi: 10.1080/14656566.2020.1858795. Epub 2020 Dec 31.

Author

Michael L Mathai^{1

2}

Affiliations

¹ College of Health and Biomedicine, Institute of Health and Sport, Victoria University , Melbourne, Australia.
² Florey Institute of Neuroscience and Mental Health , Melbourne, Australia.

PMID: 33382010
DOI: 10.1080/14656566.2020.1858795

No abstract available

Keywords: Belviq; Diabetes risk; food appetite; serotonin 5HT2c receptor.

Publication types

Editorial

MeSH terms

Anti-Obesity Agents*
Benzazepines / therapeutic use
Camellia*
Humans
Serotonin 5-HT2 Receptor Agonists

Substances

Anti-Obesity Agents
Benzazepines
Serotonin 5-HT2 Receptor Agonists
lorcaserin